RESUMO
The segmentation of organs and structures is a critical component of radiation therapy planning, with manual segmentation being a laborious and time-consuming task. Interobserver variability can also impact the outcomes of radiation therapy. Deep neural networks have recently gained attention for their ability to automate segmentation tasks, with convolutional neural networks (CNNs) being a popular approach. This article provides a descriptive review of the literature on deep learning (DL) techniques for segmentation in radiation therapy planning. This review focuses on five clinical sub-sites and finds that U-net is the most commonly used CNN architecture. The studies using DL for image segmentation were included in brain, head and neck, lung, abdominal, and pelvic cancers. The majority of DL segmentation articles in radiation therapy planning have concentrated on normal tissue structures. N-fold cross-validation was commonly employed, without external validation. This research area is expanding quickly, and standardization of metrics and independent validation are critical to benchmarking and comparing proposed methods.
Assuntos
Aprendizado Profundo , Radioterapia (Especialidade) , Humanos , Benchmarking , Encéfalo , CabeçaRESUMO
Radiation therapy has dramatically changed with the advent of computed tomography and intensity modulation. This added complexity to the workflow but allowed for more precise and reproducible treatment. As a result, these advances required the accurate delineation of many more volumes, raising questions about how to delineate them, in a uniform manner across centers. Then, as computing power improved, reverse planning became possible and three-dimensional dose distributions could be generated. Artificial intelligence offers the opportunity to make such workflow more efficient while increasing practice homogeneity. Many artificial intelligence-based tools are being implemented in routine practice to increase efficiency, reduce workload and improve homogeneity of treatments. Data retrieved from this workflow could be combined with clinical data and omic data to develop predictive tools to support clinical decision-making process. Such predictive tools are at the stage of proof-of-concept and need to be explainatory, prospectively validated, and based on large and multicenter cohorts. Nevertheless, they could bridge the gap to personalized radiation oncology, by personalizing oncologic strategies, dose prescriptions to tumor volumes and dose constraints to organs at risk.
RESUMO
Radiotherapy (RT) for high-risk localized prostate cancer (HRLPC) can be controversial in the context of increasing detection of suspicious lymph nodes via advanced imaging techniques. The EORTC 22683 trial initially established RT with androgen deprivation therapy (ADT) as the standard of care for HRLPC, but many patients remain uncured. GETUG-AFU-12 showed that addition of docetaxel and estramustine to ADT improved relapse-free survival but not overall survival. STAMPEDE later demonstrated that abiraterone acetate with ADT and RT significantly improved failure-free survival and overall survival. Ongoing trials such as ENZARAD, ATLAS, DASL-HiCap, and GETUG-P17 ALADDIN are investigating the efficacy of new androgen receptor pathway inhibitors combined with RT and ADT. These studies aim to refine treatment strategies for HRLPC, particularly in the context of advanced imaging and patient upstaging. PATIENT SUMMARY: Addition of newer medications to standard radiation therapy has shown promise in improving survival for men with high-risk prostate cancer. Ongoing studies are testing these options to find the best combination. The aim is to increase the chances of curing prostate cancer, especially as advanced scan techniques are detecting more cases.
RESUMO
BACKGROUND AND PURPOSE: Studies investigating the application of Artificial Intelligence (AI) in the field of radiotherapy exhibit substantial variations in terms of quality. The goal of this study was to assess the amount of transparency and bias in scoring articles with a specific focus on AI based segmentation and treatment planning, using modified PROBAST and TRIPOD checklists, in order to provide recommendations for future guideline developers and reviewers. MATERIALS AND METHODS: The TRIPOD and PROBAST checklist items were discussed and modified using a Delphi process. After consensus was reached, 2 groups of 3 co-authors scored 2 articles to evaluate usability and further optimize the adapted checklists. Finally, 10 articles were scored by all co-authors. Fleiss' kappa was calculated to assess the reliability of agreement between observers. RESULTS: Three of the 37 TRIPOD items and 5 of the 32 PROBAST items were deemed irrelevant. General terminology in the items (e.g., multivariable prediction model, predictors) was modified to align with AI-specific terms. After the first scoring round, further improvements of the items were formulated, e.g., by preventing the use of sub-questions or subjective words and adding clarifications on how to score an item. Using the final consensus list to score the 10 articles, only 2 out of the 61 items resulted in a statistically significant kappa of 0.4 or more demonstrating substantial agreement. For 41 items no statistically significant kappa was obtained indicating that the level of agreement among multiple observers is due to chance alone. CONCLUSION: Our study showed low reliability scores with the adapted TRIPOD and PROBAST checklists. Although such checklists have shown great value during development and reporting, this raises concerns about the applicability of such checklists to objectively score scientific articles for AI applications. When developing or revising guidelines, it is essential to consider their applicability to score articles without introducing bias.
Assuntos
Inteligência Artificial , Lista de Checagem , Técnica Delphi , Planejamento da Radioterapia Assistida por Computador , Humanos , Planejamento da Radioterapia Assistida por Computador/métodos , Planejamento da Radioterapia Assistida por Computador/normas , Guias de Prática Clínica como Assunto , Viés , Reprodutibilidade dos Testes , Neoplasias/radioterapiaRESUMO
BACKGROUND AND PURPOSE: Artificial Intelligence (AI) models in radiation therapy are being developed with increasing pace. Despite this, the radiation therapy community has not widely adopted these models in clinical practice. A cohesive guideline on how to develop, report and clinically validate AI algorithms might help bridge this gap. METHODS AND MATERIALS: A Delphi process with all co-authors was followed to determine which topics should be addressed in this comprehensive guideline. Separate sections of the guideline, including Statements, were written by subgroups of the authors and discussed with the whole group at several meetings. Statements were formulated and scored as highly recommended or recommended. RESULTS: The following topics were found most relevant: Decision making, image analysis, volume segmentation, treatment planning, patient specific quality assurance of treatment delivery, adaptive treatment, outcome prediction, training, validation and testing of AI model parameters, model availability for others to verify, model quality assurance/updates and upgrades, ethics. Key references were given together with an outlook on current hurdles and possibilities to overcome these. 19 Statements were formulated. CONCLUSION: A cohesive guideline has been written which addresses main topics regarding AI in radiation therapy. It will help to guide development, as well as transparent and consistent reporting and validation of new AI tools and facilitate adoption.